Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Upstream Bio (NASDAQ:UPB) through any online brokerage.
Other companies in Upstream Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Upstream Bio has a consensus price target of $36.14.
The stock price for Upstream Bio (NASDAQ: UPB) is $3.045 last updated October 20, 2026 at 10:57 AM EDT.
There are no upcoming dividends for Upstream Bio.
Upstream Bio does not have any upcoming earnings scheduled.
There is no upcoming split for Upstream Bio.
Upstream Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.